Computational close up on protein-protein interactions: How to unravel the invisible using molecular dynamics simulations?

Wiley Interdisciplinary Reviews: Computational Molecular Science

Volumn 5, Issue 5, 2015, Pages 345-359

  Rakers, Christin ^a   Bermudez, Marcel ^a   Keller, Bettina G ^a   Mortier, Jérémie ^a   Wolber, Gerhard ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES; COMPUTATIONAL CHEMISTRY; MACROMOLECULES; MOLECULAR DYNAMICS;

EXPERIMENTAL TECHNIQUES; MACROMOLECULAR STRUCTURES; MOLECULAR DYNAMICS SIMULATIONS; PROTEIN-PROTEIN INTERACTIONS; PROTEIN-PROTEIN INTERFACE; SMALL MOLECULE INHIBITOR; STRUCTURAL INVESTIGATION; TECHNOLOGICAL CHALLENGES;

PROTEINS;

EID: 84940447298     PISSN: 17590876     EISSN: 17590884     Source Type: Journal    
DOI: 10.1002/wcms.1222     Document Type: Review

References (107)

1. Khanna I. Drug discovery in pharmaceutical industry: productivity challenges and trends. Drug Discov Today 2012, 17:1088-1102.
2. Stumpf MP, Thorne T, de Silva E, Stewart R, An HJ, Lappe M, Wiuf C. Estimating the size of the human interactome. Proc Natl Acad Sci U S A 2008, 105:6959-6964.
3. Venkatesan K, Rual JF, Vazquez A, Stelzl U, Lemmens I, Hirozane-Kishikawa T, Hao T, Zenkner M, Xin X, Goh KI, et al. An empirical framework for binary interactome mapping. Nat Methods 2009, 6:83-90.
4. Zhang QC, Petrey D, Deng L, Qiang L, Shi Y, Thu CA, Bisikirska B, Lefebvre C, Accili D, Hunter T, et al. Structure-based prediction of protein-protein interactions on a genome-wide scale. Nature 2012, 490:556-560.
5. Havugimana PC, Hart GT, Nepusz T, Yang H, Turinsky AL, Li Z, Wang PI, Boutz DR, Fong V, Phanse S, et al. A census of human soluble protein complexes. Cell 2012, 150:1068-1081.
6. Rolland T, Taşan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N, Yi S, Lemmens I, Fontanillo C, Mosca R, et al. A proteome-scale map of the human interactome network. Cell 2014, 159:1212-1226.
7. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res 2000, 28:235-242.
8. Stein A, Mosca R, Aloy P. Three-dimensional modeling of protein interactions and complexes is going 'omics. Curr Opin Struct Biol 2011, 21:200-208.
9. Szilagyi A, Zhang Y. Template-based structure modeling of protein-protein interactions. Curr Opin Struct Biol 2014, 24:10-23.
10. Wells JA, McClendon CL. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 2007, 450:1001-1009.
11. Arkin MR, Wells JA. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 2004, 3:301-317.
12. Moreira IS, Fernandes PA, Ramos MJ. Hot spots-a review of the protein-protein interface determinant amino-acid residues. Proteins 2007, 68:803-812.
13. Nooren IM, Thornton JM. Diversity of protein-protein interactions. EMBO J 2003, 22:3486-3492.
14. Dror RO, Dirks RM, Grossman JP, Xu H, Shaw DE. Biomolecular simulation: a computational microscope for molecular biology. Annu Rev Biophys 2012, 41:429-452.
15. Koehl P. Electrostatics calculations: latest methodological advances. Curr Opin Struct Biol 2006, 16:142-151.
16. Martinez-Mayorga K, Pitman MC, Grossfield A, Feller SE, Brown MF. Retinal counterion switch mechanism in vision evaluated by molecular simulations. J Am Chem Soc 2006, 128:16502-16503.
17. Shaw DE, Maragakis P, Lindorff-Larsen K, Piana S, Dror RO, Eastwood MP, Bank JA, Jumper JM, Salmon JK, Shan Y, et al. Atomic-level characterization of the structural dynamics of proteins. Science 2010, 330:341-346.
18. Shirts M, Pande VS. Computing: screen savers of the world unite!. Science 2000, 290:1903-1904.
19. Voelz VA, Bowman GR, Beauchamp K, Pande VS. Molecular simulation of ab initio protein folding for a millisecond folder NTL9(1-39). J Am Chem Soc 2010, 132:1526-1528.
20. Lane TJ, Shukla D, Beauchamp KA, Pande VS. To milliseconds and beyond: challenges in the simulation of protein folding. Curr Opin Struct Biol 2013, 23:58-65.
21. Saunders MG, Voth GA. Coarse-graining methods for computational biology. Annu Rev Biophys 2013, 42:73-93.
22. Kaptein R, Zuiderweg ER, Scheek RM, Boelens R, van Gunsteren WF. A protein structure from nuclear magnetic resonance data. lac repressor headpiece. J Mol Biol 1985, 182:179-182.
23. Keller B, Christen M, Oostenbrink C, van Gunsteren WF. On using oscillating time-dependent restraints in MD simulation. J Biomol NMR 2007, 37:1-14.
24. Fisette O, Lague P, Gagne S, Morin S. Synergistic applications of MD and NMR for the study of biological systems. J Biomed Biotechnol 2012, 2012:254208.
25. Zwanzig RW. High-temperature equation of state by a perturbation method. I. Nonpolar gases. J Chem Physics 1954, 22:1420-1426.
26. Chodera JD, Mobley DL, Shirts MR, Dixon RW, Branson K, Pande VS. Alchemical free energy methods for drug discovery: progress and challenges. Curr Opin Struct Biol 2011, 21:150-160.
27. Mobley DL, Klimovich PV. Perspective: alchemical free energy calculations for drug discovery. J Chem Phys 2012, 137:230901.
28. Liu S, Wu Y, Lin T, Abel R, Redmann JP, Summa CM, Jaber VR, Lim NM, Mobley DL. Lead optimization mapper: automating free energy calculations for lead optimization. J Comput Aided Mol Des 2013, 27:755-770.
29. Bolhuis PG, Chandler D, Dellago C, Geissler PL. Transition path sampling: throwing ropes over rough mountain passes, in the dark. Annu Rev Phys Chem 2002, 53:291-318.
30. Faradjian AK, Elber R. Computing time scales from reaction coordinates by milestoning. J Chem Phys 2004, 120:10880-10889.
31. Prinz JH, Wu H, Sarich M, Keller B, Senne M, Held M, Chodera JD, Schutte C, Noe F. Markov models of molecular kinetics: generation and validation. J Chem Phys 2011, 134:174105.
32. Noe F, Schutte C, Vanden-Eijnden E, Reich L, Weikl TR. Constructing the equilibrium ensemble of folding pathways from short off-equilibrium simulations. Proc Natl Acad Sci U S A 2009, 106:19011-19016.
33. Du W, Bolhuis PG. Sampling the equilibrium kinetic network of Trp-cage in explicit solvent. J Chem Phys 2014, 140:195102.
34. Kelley NW, Vishal V, Krafft GA, Pande VS. Simulating oligomerization at experimental concentrations and long timescales: a Markov state model approach. J Chem Phys 2008, 129:214707.
35. Durrant JD, McCammon JA. Molecular dynamics simulations and drug discovery. BMC Biol 2011, 9:71.
36. Bowman GR, Geissler PL. Equilibrium fluctuations of a single folded protein reveal a multitude of potential cryptic allosteric sites. Proc Natl Acad Sci U S A 2012, 109:11681-11686.
37. Buch I, Giorgino T, De Fabritiis G. Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations. Proc Natl Acad Sci U S A 2011, 108:10184-10189.
38. Risselada HJ, Grubmuller H. How SNARE molecules mediate membrane fusion: recent insights from molecular simulations. Curr Opin Struct Biol 2012, 22:187-196.
39. Noe F, Doose S, Daidone I, Lollmann M, Sauer M, Chodera JD, Smith JC. Dynamical fingerprints for probing individual relaxation processes in biomolecular dynamics with simulations and kinetic experiments. Proc Natl Acad Sci U S A 2011, 108:4822-4827.
40. Keller BG, Prinz J-H, Noé F. Markov models and dynamical fingerprints: unraveling the complexity of molecular kinetics. Chem Phys 2012, 396:92-107.
41. Mortier J, Rakers C, Bermudez M, Murgueitio MS, Riniker S, Wolber G. The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexes. Drug Discov Today 2015, 20:686-702.
42. Huang SY. Exploring the potential of global protein-protein docking: an overview and critical assessment of current programs for automatic ab initio docking. Drug Discov Today 2015. doi: 10.1016/j.drudis.2015.03.007. [Epub ahead of print]
43. Chen YC. Beware of docking!. Trends Pharmacol Sci 2015, 36:78-95.
44. Kastritis PL, Bonvin AM. Are scoring functions in protein-protein docking ready to predict interactomes? Clues from a novel binding affinity benchmark. J Proteome Res 2010, 9:2216-2225.
45. Moreira IS, Martins JM, Coimbra JT, Ramos MJ, Fernandes PA. A new scoring function for protein-protein docking that identifies native structures with unprecedented accuracy. Phys Chem Chem Phys 2015, 17:2378-2387.
46. Shan Y, Gnanasambandan K, Ungureanu D, Kim ET, Hammaren H, Yamashita K, Silvennoinen O, Shaw DE, Hubbard SR. Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase. Nat Struct Mol Biol 2014, 21:579-584.
47. Chapman DE, Steck JK, Nerenberg PS. Optimizing protein-protein van der Waals interactions for the AMBER ff9x/ff12 force field. J Chem Theory Comput 2013, 10:273-281.
48. Petrov D, Zagrovic B. Are current atomistic force fields accurate enough to study proteins in crowded environments? PLoS Comput Biol 2014, 10:e1003638.
49. Eyrisch S, Helms V. Transient pockets on protein surfaces involved in protein-protein interaction. J Med Chem 2007, 50:3457-3464.
50. Eyrisch S, Medina-Franco JL, Helms V. Transient pockets on XIAP-BIR2: toward the characterization of putative binding sites of small-molecule XIAP inhibitors. J Mol Model 2012, 18:2031-2042.
51. Arkin MR, Randal M, DeLano WL, Hyde J, Luong TN, Oslob JD, Raphael DR, Taylor L, Wang J, McDowell RS, et al. Binding of small molecules to an adaptive protein-protein interface. Proc Natl Acad Sci U S A 2003, 100:1603-1608.
52. Eyrisch S, Helms V. What induces pocket openings on protein surface patches involved in protein-protein interactions? J Comput Aided Mol Des 2009, 23:73-86.
53. Kokh DB, Richter S, Henrich S, Czodrowski P, Rippmann F, Wade RC. TRAPP: a tool for analysis of transient binding pockets in proteins. J Chem Inf Model 2013, 53:1235-1252.
54. Dixit A, Verkhivker GM. Probing molecular mechanisms of the Hsp90 chaperone: biophysical modeling identifies key regulators of functional dynamics. PLoS One 2012, 7:e37605.
55. Bastianelli G, Bouillon A, Nguyen C, Crublet E, Pêtres S, Gorgette O, Le-Nguyen D, Barale JC, Nilges M. Computational reverse-engineering of a spider-venom derived peptide active against Plasmodium falciparum SUB1. PLoS One 2011, 6:e21812.
56. Hashimoto K, Nishi H, Bryant S, Panchenko AR. Caught in self-interaction: evolutionary and functional mechanisms of protein homooligomerization. Phys Biol 2011, 8:035007.
57. Chandler DE, Penin F, Schulten K, Chipot C. The p7 protein of hepatitis C virus forms structurally plastic, minimalist ion channels. PLoS Comput Biol 2012, 8:e1002702.
58. Massova I, Kollman PA. Computational alanine scanning to probe protein-protein interactions: a novel approach to evaluate binding free energies. J Am Chem Soc 1999, 121:8133-8143.
59. Sousa SF, Tamames B, Fernandes PA, Ramos MJ. Detailed atomistic analysis of the HIV-1 protease interface. J Phys Chem B 2011, 115:7045-7057.
60. Meier C, Cairns-Smith S, Schulze U. Can emerging drug classes improve R&D productivity? Drug Discov Today 2013, 18:607-609.
61. Nero TL, Morton CJ, Holien JK, Wielens J, Parker MW. Oncogenic protein interfaces: small molecules, big challenges. Nat Rev Cancer 2014, 14:248-262.
62. Arkin MR, Tang Y, Wells JA. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality. Chem Biol 2014, 21:1102-1114.
63. Ryan DP, Matthews JM. Protein-protein interactions in human disease. Curr Opin Struct Biol 2005, 15:441-446.
64. Nevola L, Giralt E. Modulating protein-protein interactions: the potential of peptides. Chem Commun (Camb) 2015, 51:3302-3315.
65. Block P, Weskamp N, Wolf A, Klebe G. Strategies to search and design stabilizers of protein-protein interactions: a feasibility study. Proteins 2007, 68:170-186.
66. Thiel P, Kaiser M, Ottmann C. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery? Angew Chem Int Ed Engl 2012, 51:2012-2018.
67. Voet A, Banwell EF, Sahu KK, Heddle JG, Zhang KY. Protein interface pharmacophore mapping tools for small molecule protein: protein interaction inhibitor discovery. Curr Top Med Chem 2013, 13:989-1001.
68. De Luca L, Barreca ML, Ferro S, Christ F, Iraci N, Gitto R, Monforte AM, Debyser Z, Chimirri A. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75. ChemMedChem 2009, 4:1311-1316.
69. Murgueitio MS, Henneke P, Glossmann H, Santos-Sierra S, Wolber G. Prospective virtual screening in a sparse data scenario: design of small-molecule TLR2 antagonists. ChemMedChem 2014, 9:813-822.
70. Wolber G, Langer T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 2005, 45:160-169.
71. Wolber G, Dornhofer AA, Langer T. Efficient overlay of small organic molecules using 3D pharmacophores. J Comput Aided Mol Des 2006, 20:773-788.
72. Corradi V, Mancini M, Manetti F, Petta S, Santucci MA, Botta M. Identification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis. Bioorg Med Chem Lett 2010, 20:6133-6137.
73. Meli M, Pagano K, Ragona L, Colombo G. Investigating the dynamic aspects of drug-protein recognition through a combination of MD and NMR analyses: implications for the development of protein-protein interaction inhibitors. PLoS One 2014, 9:e97153.
74. Fuller JC, Jackson RM, Edwards TA, Wilson AJ, Shirts MR. Modeling of arylamide helix mimetics in the p53 peptide binding site of hDM2 suggests parallel and anti-parallel conformations are both stable. PLoS One 2012, 7:e43253.
75. Zhou H, Liu L, Huang J, Bernard D, Karatas H, Navarro A, Lei M, Wang S. Structure-based design of high-affinity macrocyclic peptidomimetics to block the menin-mixed lineage leukemia 1 (MLL1) protein-protein interaction. J Med Chem 2013, 56:1113-1123.
76. Yang CY, Wang S. Computational analysis of protein hotspots. ACS Med Chem Lett 2010, 1:125-129.
77. Mattos C, Ringe D. Locating and characterizing binding sites on proteins. Nat Biotechnol 1996, 14:595-599.
78. Yang CY, Wang S. Hydrophobic binding hot spots of Bcl-xL protein-protein interfaces by cosolvent molecular dynamics simulation. ACS Med Chem Lett 2011, 2:280-284.
79. Craik DJ, Fairlie DP, Liras S, Price D. The future of peptide-based drugs. Chem Biol Drug Des 2013, 81:136-147.
80. Woolfson DN. The design of coiled-coil structures and assemblies. Adv Protein Chem 2005, 70:79-112.
81. Rezaei Araghi R, Jackel C, Colfen H, Salwiczek M, Volkel A, Wagner SC, Wieczorek S, Baldauf C, Koksch B. A β/γ motif to mimic α-helical turns in proteins. ChemBioChem 2010, 11:335-339.
82. Nyakatura EK, Rezaei Araghi R, Mortier J, Wieczorek S, Baldauf C, Wolber G, Koksch B. An unusual interstrand H-bond stabilizes the heteroassembly of helical αβγ-chimeras with natural peptides. ACS Chem Biol 2014, 9:613-616.
83. Nyakatura EK, Mortier J, Radtke VS, Wieczorek S, Rezaei Araghi R, Baldauf C, Wolber G, Koksch B. β- and γ- amino acids at α-helical interfaces: toward the formation of highly stable foldameric coiled coils. ACS Med Chem Lett 2014, 5:1300-1303.
84. Mortier J, Nyakatura EK, Reimann O, Huhmann S, Daldrop JO, Baldauf C, Wolber G, Miettinen MS, Koksch B. Coiled-coils in phage display screening: insight into exceptional selectivity provided by molecular dynamics. J Chem Inf Model 2015, 55:495-500.
85. Liu L, Ghosh N, Slivka PF, Fiorini Z, Hutchinson MR, Watkins LR, Yin H. An MD2 hot-spot-mimicking peptide that suppresses TLR4-mediated inflammatory response in vitro and in vivo. ChemBioChem 2011, 12:1827-1831.
86. Giménez-Oya V, Villacañas O, Obiol-Pardo C, Antolin-Llovera M, Rubio-Martinez J, Imperial S. Design of novel ligands of CDP-methylerythritol kinase by mimicking direct protein-protein and solvent-mediated interactions. J Mol Recognit 2011, 24:71-80.
87. Beck A, Wurch T, Bailly C, Corvaia N. Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol 2010, 10:345-352.
88. Fang X, Fang Y, Liu L, Liu G, Wu J. Mapping paratope on antithrombotic antibody 6B4 to epitope on platelet glycoprotein Ibα via molecular dynamic simulations. PLoS One 2012, 7:e42263.
89. Chaudhri A, Zarraga IE, Kamerzell TJ, Brandt JP, Patapoff TW, Shire SJ, Voth GA. Coarse-grained modeling of the self-association of therapeutic monoclonal antibodies. J Phys Chem B 2012, 116:8045-8057.
90. Schmidt AG, Xu H, Khan AR, O'Donnell T, Khurana S, King LR, Manischewitz J, Golding H, Suphaphiphat P, Carfi A, et al. Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proc Natl Acad Sci U S A 2013, 110:264-269.
91. Lawson CL, Baker ML, Best C, Bi C, Dougherty M, Feng P, van Ginkel G, Devkota B, Lagerstedt I, Ludtke SJ, et al. EMDataBank.org: unified data resource for CryoEM. Nucleic Acids Res 2011, 39:D456-D464.
92. Trabuco LG, Villa E, Mitra K, Frank J, Schulten K. Flexible fitting of atomic structures into electron microscopy maps using molecular dynamics. Structure 2008, 16:673-683.
93. Trabuco LG, Villa E, Schreiner E, Harrison CB, Schulten K. Molecular dynamics flexible fitting: a practical guide to combine cryo-electron microscopy and x-ray crystallography. Methods 2009, 49:174-180.
94. Beck F, Unverdorben P, Bohn S, Schweitzer A, Pfeifer G, Sakata E, Nickell S, Plitzko JM, Villa E, Baumeister W, et al. Near-atomic resolution structural model of the yeast 26S proteasome. Proc Natl Acad Sci U S A 2012, 109:14870-14875.
95. Schönegge AM, Villa E, Förster F, Hegerl R, Peters J, Baumeister W, Rockel B. The structure of human tripeptidyl peptidase II as determined by a hybrid approach. Structure 2012, 20:593-603.
96. Baaden M, Marrink SJ. Coarse-grain modelling of protein-protein interactions. Curr Opin Struct Biol 2013, 23:878-886.
97. Gamini R, Han W, Stone JE, Schulten K. Assembly of Nsp1 nucleoporins provides insight into nuclear pore complex gating. PLoS Comput Biol 2014, 10:e1003488.
98. Moussavi-Baygi R, Jamali Y, Karimi R, Mofrad MR. Brownian dynamics simulation of nucleocytoplasmic transport: a coarse-grained model for the functional state of the nuclear pore complex. PLoS Comput Biol 2011, 7:e1002049.
99. Zhao CL, Mahboobi SH, Moussavi-Baygi R, Mofrad MR. The interaction of CRM1 and the nuclear pore protein Tpr. PLoS One 2014, 9:e93709.
100. Goley ED, Welch MD. The ARP2/3 complex: an actin nucleator comes of age. Nat Rev Mol Cell Biol 2006, 7:713-726.
101. Pfaendtner J, Volkmann N, Hanein D, Dalhaimer P, Pollard TD, Voth GA. Key structural features of the actin filament Arp2/3 complex branch junction revealed by molecular simulation. J Mol Biol 2012, 416:148-161.
102. Zheng W, Barua B, Hitchcock-DeGregori SE. Probing the flexibility of tropomyosin and its binding to filamentous actin using molecular dynamics simulations. Biophys J 2013, 105:1882-1892.
103. Baker JL, Voth GA. Effects of ATP and actin-filament binding on the dynamics of the myosin II S1 domain. Biophys J 2013, 105:1624-1634.
104. Adelstein RS, Eisenberg E. Regulation and kinetics of the actin-myosin-ATP interaction. Annu Rev Biochem 1980, 49:921-956.
105. Cheng S, Stevens MJ. Self-assembly of chiral tubules. Soft Matter 2014, 10:510-518.
106. Garzoni M, Okuro K, Ishii N, Aida T, Pavan GM. Structure and shape effects of molecular glue on supramolecular tubulin assemblies. ACS Nano 2014, 8:904-914.
107. Redwine WB, Hernández-López R, Zou S, Huang J, Reck-Peterson SL, Leschziner AE. Structural basis for microtubule binding and release by dynein. Science 2012, 337:1532-1536.